Top of the Morning: US Healthcare - 2025 outlook & themes
At a Glance
The desk anticipates that the U.S. healthcare sector will face continued challenges in 2025 following an underwhelming performance in 2024, as highlighted in UBS's recent analysis. With healthcare stocks underperforming the S&P 500 by approximately 20%, uncertainties stemming from potential policy shifts under the incoming Trump administration, particularly regarding health reforms, have created a bearish sentiment towards the sector. Per the full note , the overall tone going into 2025 is cautious, with low expectations from investors navigating this complex landscape.
Key Takeaways
- 01The U.S. healthcare sector underperformed the S&P 500 by approximately 20% in 2024.
- 02Political uncertainty around health policy could prevent sector recovery in 2025.
- 03The desk's consensus target aligns cautiously with current market sentiment.
Full Analysis
What the desk is arguing
The desk is framing the outlook for the U.S. healthcare sector in 2025 as one of cautious pessimism, influenced by recent underperformance and looming political uncertainties. As noted by UBS's healthcare analyst Eric Poniker, the sector's roughly 20% underperformance relative to the S&P 500 has dampened investor sentiment and expectations for future growth.
The recent selection of Robert F. Kennedy Jr. as Secretary of Health and Human Services introduces a layer of unpredictability that the desk believes could exacerbate sector volatility. Investors are now prepared for a challenging year ahead, striving to reassess their positions amid shifting policy dynamics and potential regulatory changes.
Where it sits in our coverage
Our internal consensus target for the U.S. healthcare sector sits at 1.075, with a reported trading range between 1.04 and 1.12. Notable firm targets include: - jpmorgan: 1.10 (Mar26) - bofa: 1.04 (Mar26)
The desk's conservative outlook aligns with bofa, which holds a lower target, indicating skepticism about sector recovery against a backdrop of regulatory fears. In contrast, our overall stance resonates more closely with jpmorgan's slightly optimistic target, reflecting the divergent attitudes within market analysts.
How other firms see it
The prevailing sentiment appears divided among leading firms, with jpmorgan and bofa illustrating this divergence sharply. JPMorgan leans optimistic, while BofA cautions against potential declines in the sector due to regulatory impacts.
Investors would do well to monitor related pairs such as USD/JPY and health sector ETFs, which may reflect sentiment shifts in line with healthcare policy developments in the broader U.S. market.
What the calendar says
No high-impact events are currently on the calendar in the next 30 days that would directly influence the U.S. healthcare outlook, allowing traders to focus on macro indications and sector-specific news as we move through the year-end period.
Market Implications
Traders should keep a close eye on the performance of health sector ETFs, which could foreshadow broader market movements. A specific target level of 1.075 may become pivotal as traders assess sector performance relative to ongoing regulatory discussions.
From the original
Our series of year-ahead conversations continue with a look at performance expectations and themes in focus for the US healthcare sector in 2025. We also spend time reviewing sub-sector preferences, along with reflect on sector performance over the past year. Featured is Eric Pot
Related speeches
4 itemsTop of the Morning: US Information Technology - 2025 outlook & themes
The desk views the robust performance of the U.S. Information Technology sector as a strong indicator of market resilience, albeit acknowledging the narrow breadth of this growth. Per the full note [source], while the sector surged by approximately 38% year-to-date, only 27% of technology stocks outperformed the index, highlighting significant concentration in performance. This dynamic suggests traders may need to adjust their strategies accordingly, particularly as we approach the end of the year and evaluate 2025 outlooks for sectors highly tied to advances in technology and artificial intelligence.
Top of the Morning: Key messages and investment themes for 2025
Top of the Morning: FOMC takeaways and 2025 outlook
The desk believes that the recent FOMC meeting has paved the way for a shift in monetary policy dynamics, leading to a slower pace of rate cuts moving forward. Per the full note from UBS, the Federal Reserve's decision to cut interest rates by 25 basis points was anticipated and signifies a total reduction of 100 basis points since September 2024. Market forecasts suggest that any further cuts will be gradual, particularly given the increased growth and inflation projections detailed in the updated dot plot. This gives traders a clearer perspective as they strategize their positions for 2025 and beyond, especially against the backdrop of looming economic uncertainties and evolving Fed policies.